Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014–2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and safety with that of trivalent inactivated influenza v...

Full description

Bibliographic Details
Main Authors: Sanie Sesay, Jerzy Brzostek, Ingo Meyer, Yves Donazzolo, Geert Leroux-Roels, Régine Rouzier, Béatrice Astruc, Henryk Szymanski, Nicole Toursarkissian, Corinne Vandermeulen, Edyta Kowalska, Pierre Van Damme, Camille Salamand, Stephanie Pepin
Format: Article
Language:English
Published: Taylor & Francis Group 2018-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
adult
elderly
immunogenicity
inactivated influenza vaccine
randomized controlled trial
safety
quadrivalent influenza vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2017.1384106

Internet

http://dx.doi.org/10.1080/21645515.2017.1384106

Similar Items